Skip to main content

Evolv Technologies Holdings, Inc.

For the period ended Jun 30, 2026. Filed Aug 11, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 11, 2026

EVLV$4.44-6.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

June 30, 2026December 31, 2025
Assets
Current assets:
Cash and cash equivalents$52,696$49,150
Restricted cash733—
Marketable securities9,93619,885
Accounts receivable, net of allowance for expected credit losses of $700 and $600 as of June 30, 2026 and December 31, 2025, respectively39,57530,841
Inventory8,6609,317
Current portion of contract assets2,525878
Current portion of commission asset5,5966,062
Prepaid expenses and other current assets29,68635,169
Total current assets149,407151,302
Contract assets, noncurrent715
Commission asset, noncurrent7,7167,867
Property and equipment, net128,962127,522
Operating lease right-of-use assets11,42812,303
Other assets4,5035,400
Total assets$302,023$304,409
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$12,252$9,770
Accrued expenses and other current liabilities37,01735,293
Current portion of deferred revenue74,46474,924
Current portion of operating lease liabilities3,1162,989
Total current liabilities126,849122,976
Deferred revenue, noncurrent17,78116,716
Long-term debt28,73728,596
Operating lease liabilities, noncurrent9,71510,654
Contingent earn-out liability, noncurrent—374
Contingently issuable common stock liability, noncurrent—1,809
Public warrant liability, noncurrent833,862
Total liabilities183,165184,987
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 100,000,000 authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025——
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at June 30, 2026 and December 31, 2025; 180,839,400 and 175,399,488 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively1818
Additional paid-in capital521,062507,347
Accumulated other comprehensive loss(113)(141)
Accumulated deficit(402,109)(387,802)
Stockholders’ equity118,858119,422
Total liabilities and stockholders’ equity$302,023$304,409
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.